DrugDashboards

Imiquimod

Imiquimod · IMIQUIMOD 50 mg/g · Cream · Topical · Sun Pharmaceutical Industries, Inc.

NDC 51672-4145-06 · 24 PACKET in 1 CARTON / .25 g in 1 PACKET · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 21% over the past year, to $0.6445 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.6445per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$2.00per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$1.37per GMweighted avg manufacturer price $0.7820 · May 1, 2024212% of what pharmacies pay — higher than 90% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00$15.00Nov 2013Sep 2026$0.6445
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$75.00
Reported to Texas DSHS · 2026 annual filing · Taro

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$115,446
4,409 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 20% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for imiquimod (other) in the next 90 days

price up 19% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA200173
TE code
AB
Approval date
Apr 15, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Imiquimod (Cream)

LabelerStrengthFirst seenLast seen
Bausch Health US, LLCIMIQUIMOD 37.5 mg/gJul 15, 2026Sep 3, 2026
Bryant Ranch PrepackIMIQUIMOD 12.5 mg/.25gJul 15, 2026Sep 3, 2026
Bausch Health US, LLCIMIQUIMOD 2.5 mg/gJul 15, 2026Sep 2, 2026
Direct RxIMIQUIMOD 12.5 mg/.25gJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAIMIQUIMOD 50 mg/gJul 15, 2026Sep 2, 2026
Oceanside PharmacueticalsIMIQUIMOD 37.5 mg/gJul 15, 2026Sep 2, 2026
Padagis Israel Pharmaceuticals LtdIMIQUIMOD 12.5 mg/.25gJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.IMIQUIMOD 37.5 mg/gJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.IMIQUIMOD 50 mg/gJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.IMIQUIMOD 37.5 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Imiquimod — NDC 51672-4145-06," retrieved September 3, 2026, https://drugdashboards.com/drug/51672414506.

Free to cite with attribution — see how the data is put together.